CN Patent

CN104926800A — 一种阿法替尼二马来酸盐的结晶形式及其制备方法

Assigned to HEBEI SHINEWAY PHARMACEUTICAL CO Ltd · Expires 2015-09-23 · 11y expired

What this patent protects

本发明涉及一种阿法替尼二马来酸盐的结晶形式及其制备方法，含其的药物组合物及其药物组合物在抗癌药物中的应用。该结晶形式X-射线粉末衍射图谱在衍射角2θ为4.9±0.2°、10.5±0.2°、12.8±0.2°、17.2±0.2°、19.8±0.2°处具有特征峰，其熔点为168.68。

USPTO Abstract

本发明涉及一种阿法替尼二马来酸盐的结晶形式及其制备方法，含其的药物组合物及其药物组合物在抗癌药物中的应用。该结晶形式X-射线粉末衍射图谱在衍射角2θ为4.9±0.2°、10.5±0.2°、12.8±0.2°、17.2±0.2°、19.8±0.2°处具有特征峰，其熔点为168.68。

Drugs covered by this patent

Patent Metadata

Patent number
CN104926800A
Jurisdiction
CN
Classification
—
Expires
2015-09-23
Drug substance claim
No
Drug product claim
No
Assignee
HEBEI SHINEWAY PHARMACEUTICAL CO Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.